Lexicon Pharma (LXRX) Misses Q2 EPS by 4c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Unity Software stock soars 22% on strong Q3 beat, robust guidance
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.48 | 52 Week High | $19.62 | |||
| Open | $1.48 | 52 Week Low | $7.65 | |||
| Day High | $1.48 | P/E | N/A | |||
| Day Low | $1.48 | EPS | $-0.22 | |||
| Volume | 116,257 | |||||
